|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07J 43/00 | (2006.01) |
| A61K 31/575 | (2013.01) | ||
| C07J 31/00 | (2006.01) | ||
| A61K 31/58 | (2013.01) | ||
| C07J 43/003 | (2013.01) | ||
| C07J 33/00 | (2006.01) | ||
| C07J 33/002 | (2013.01) | ||
| A61K 31/575 | (2006.01) | ||
| A61K 31/58 | (2006.01) | ||
| C07J 9/005 | (2013.01) | ||
| A61P 1/16 | (2006.01) | ||
| C07J 9/00 | (2013.01) | ||
| A61P 9/10 | (2006.01) | ||
| C07J 41/0061 | (2013.01) | ||
| A61P 13/02 | (2006.01) | ||
| C07J 17/00 | (2013.01) | ||
| A61P 3/00 | (2006.01) | ||
| C07J 41/0094 | (2013.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 13/02 | (2018.01) | ||
| A61P 13/08 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 13/08 | (2006.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 31/14 | (2006.01) | ||
| A61P 3/04 | (2018.01) | ||
| C07J 9/00 | (2006.01) | ||
| A61P 31/14 | (2018.01) | ||
| C07J 17/00 | (2006.01) | ||
| A61P 3/06 | (2018.01) | ||
| C07J 41/00 | (2006.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 3409684 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17743740.7 |
| Date of filing the European patent application | 2017-01-25 | |
| (97) | Date of publication of the European application | 2018-12-05 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2017/072567 |
| Date | 2017-01-25 |
| (87) | Number | WO 2017/129125 |
| Date | 2017-08-03 |
| (30) | Number | Date | Country code |
| 201610061293 | 2016-01-28 | CN | |
| 201610331759 | 2016-05-18 | CN |
| (72) |
HE, Haiying , CN
XIAO, Hualing , CN
LI, Peng , CN
DU, Chunyan , CN
LUO, Zhi , CN
CHEN, Shuhui , CN
|
| (73) |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ,
No. 369 Yuzhou South Rd., Lianyungang, Jiangsu 222062,
CN
|
| (54) | STEROID DERIVATIVE FXR AGONIST |
| STEROID DERIVATIVE FXR AGONIST |